Adam S Grossman
CEO, President at Adma Biologics, Inc. (ADMA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 17SEC | ADMAAdma Biologics, Inc. | Sell Plan | 15,0002,118,777 held (−1%) | $15.16 | $227K | -31.7% |
| Mar 17SEC | ADMAAdma Biologics, Inc. | Sell Plan | 6,0002,112,777 held (−0%) | $15.16 | $91K | -31.7% |
| Feb 17SEC | ADMAAdma Biologics, Inc. | Sell Plan | 15,0002,290,379 held (−1%) | $16.08 | $241K | -35.6% |
| Feb 17SEC | ADMAAdma Biologics, Inc. | Sell Plan | 6,0002,284,379 held (−0%) | $16.08 | $96K | -35.6% |
| Dec 16SEC | ADMAAdma Biologics, Inc. | Sell Plan | 15,0002,013,850 held (−1%) | $19.79 | $297K | -47.7% |
| Dec 16SEC | ADMAAdma Biologics, Inc. | Sell Plan | 6,0002,007,850 held (−0%) | $19.79 | $119K | -47.7% |
| Nov 21SEC | ADMAAdma Biologics, Inc. | Sell Plan | 15,0002,019,850 held (−1%) | $16.00 | $240K | -35.2% |
| Nov 21SEC | ADMAAdma Biologics, Inc. | Sell Plan | 6,0002,013,850 held (−0%) | $16.00 | $96K | -35.2% |
| Oct 24SEC | ADMAAdma Biologics, Inc. | Sell Plan | 15,0002,025,850 held (−1%) | $16.00 | $240K | -35.2% |
| Oct 24SEC | ADMAAdma Biologics, Inc. | Sell Plan | 6,0002,019,850 held (−0%) | $16.00 | $96K | -35.2% |
- Sell
CEO, President Adam S Grossman sold $227K of ADMA at $15.16 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Adam S Grossman sold $91K of ADMA at $15.16 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Adam S Grossman sold $241K of ADMA at $16.08 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Adam S Grossman sold $96K of ADMA at $16.08 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Adam S Grossman sold $297K of ADMA at $19.79 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Adam S Grossman sold $119K of ADMA at $19.79 — pre-scheduled 10b5-1 plan sale.